-- Climb Bio (CLYM) has an average rating of buy and mean price target of $18.69, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Price: $11.98, Change: $+0.53, Percent Change: +4.63%